, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
ended December 31, 2019. To : The President and Governing Members of The Stock Exchange Market of Thailand Origin Property Public Company Limited and its subsidiaries hereinafter called “The Group” For
(Translation) NEP-AC 001/2560 10 August 2017 Subject : Management Discussion and Analysis for 2nd Quarter ended 30 June 2017 To : The President The Stock Exchange of Thailand Operating Result NEP
-1- AIT (VP-SEC) 026E/2017 7 November, 2017 Subject: Management's Discussion and Analysis of Operating Results for Q3-2017 To: The President of The Stock Exchange of Thailand Summary of Operations Q3
(Translation) NEP-AC 002/2560 9 November 2017 Subject : Management Discussion and Analysis for 3rd Quarter ended 30 September 2017 To : The President The Stock Exchange of Thailand Operating Result
: Management discussion and analysis for the year ended December 31, 2017 To Director and Manager of the Stock Exchange of Thailand Referring to the submission of the audited financial statements of Wiik
March 31, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For three months ended March 31, 2019 Overall Group Performance Table
MD&A Eng Q1-19 13-5-19 _1_ 1 Translation UWC 014-2019 May 14, 2019 Subject : Management Discussion and Analysis for quarter 1-2019 To : President of the Stock Exchange of Thailand Ua Withya Public
- 1 - AIT (VP-SEC) 024E/2019 August 8, 2019 Subject: Management's Discussion and Analysis of Operating Results for Q2-2019 To: The President of The Stock Exchange of Thailand Summary of Operations Q2
1 Translation UWC 022-2018 May 14, 2018 Subject : Management Discussion and Analysis for quarter 1-2018 To : President of the Stock Exchange of Thailand Ua Withya Public Company Limited ("Company